Your browser doesn't support javascript.
loading
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19.
Ameratunga, Rohan; Mears, Emily; Leung, Euphemia; Snell, Russell; Woon, See-Tarn; Kelton, William; Medlicott, Natalie; Jordan, Anthony; Abbott, William; Steele, Richard; Rolleston, William; Longhurst, Hilary; Lehnert, Klaus.
Afiliación
  • Ameratunga R; Department of Clinical immunology, Auckland Hospital, AucklandNew Zealand.
  • Mears E; Department of Virology and Immunology, Auckland Hospital, Auckland, New Zealand.
  • Leung E; Department of Molecular Medicine and Pathology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Snell R; Applied Translational Genetic Group, School of Biological Sciences, University of Auckland, Auckland, New Zealand.
  • Woon ST; Auckland Cancer Society Research Centre, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Kelton W; Applied Translational Genetic Group, School of Biological Sciences, University of Auckland, Auckland, New Zealand.
  • Medlicott N; Department of Virology and Immunology, Auckland Hospital, Auckland, New Zealand.
  • Jordan A; Te Huataki Waiora School of Health, University of Waikato, Hamilton, New Zealand.
  • Abbott W; Te Aka Matuatua School of Science, University of Waikato, Hamilton, New Zealand.
  • Steele R; School of Pharmacy, University of Otago, Dunedin, New Zealand.
  • Rolleston W; Department of Clinical immunology, Auckland Hospital, AucklandNew Zealand.
  • Longhurst H; Department of Surgery, Auckland Hospital, Auckland, New Zealand.
  • Lehnert K; Department of Respiratory Medicine, Wellington Hospital, Wellington, New Zealand.
Clin Exp Immunol ; 214(3): 289-295, 2023 12 13.
Article en En | MEDLINE | ID: mdl-37565297
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Clin Exp Immunol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Clin Exp Immunol Año: 2023 Tipo del documento: Article